We will be looking at current developments in pharmacopoeias on topics such as alternative methods, endotoxins/pyrogens and bioburden, and on the other, we will be addressing the dilemma of temperatures during the incubation of microorganisms and monitoring requirements. Another block of lectures will deal with contamination control questions under the current GMP guidelines.

This year, we are placing a special focus on the topic of Next Generation Sequencing (NGS), i.e. the activities of PharmEur in this field, the impact of ICH Q5A(R2) and the experiences of users, with our own pre-conference workshop.